China Pharma Holdings, Inc. (CPHI)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

China Pharma Holdings, Inc. (CPHI) is down 8.3% since the beginning of the year. At $1 per share, CPHI is trading 61.6% below its 52-week high of $3. Investors who bought $1,000 worth of CPHI shares 5 years ago would now be looking at an investment worth $3.

China Pharma Holdings, Inc. (CPHI) has returned -8.26% so far this year and -32.32% over the past 12 months. Over the last ten years, CPHI has returned -38.01% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.

Based on dividend-adjusted daily data since Apr 17, 2002, CPHI's average daily return is +0.18%, while the average monthly return is +1.11%. At this rate, an investment would double in approximately 5.2 years.

Historically, 37% of months were positive and 63% were negative. The best month was Jan 2003 with a return of +325.0%, while the worst month was Apr 2003 at -76.5%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 10 months.

On a daily basis, CPHI closed higher 36% of trading days. The best single day was Jan 8, 2003 with a return of +325.0%, while the worst single day was Apr 7, 2003 at -80.4%.

China Pharma Holdings, Inc. has an annualized alpha of 47.88%, beta of 0.57, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since April 17, 2002.

• This stock participated in 182.62% of S&P 500 Index downside but only 0.58% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.57 may look defensive, but with R2 of 0.01 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

CPHI ranks 40 for risk / return — above 40% of stocks peers on PortfoliosLab. Its historical combined result is near the middle of the peer group.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the China Pharma Holdings, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the China Pharma Holdings, Inc. was 100.00%, occurring on May 4, 2026. The portfolio has not yet recovered.

The current China Pharma Holdings, Inc. drawdown is 99.99%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of China Pharma Holdings, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how China Pharma Holdings, Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.